Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
2021 · Alzheimer s & Dementia · 97 citations
https://doi.org/10.1002/alz.12302
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
215
Citations
5
h-index
5
i10-index
Colleen S. Limegrover is an academic researcher from Cognition Therapeutics (United States). The author has contributed to research in topics: Computational Drug Discovery Methods & Alzheimer's disease research and treatments & Cholinesterase and Neurodegenerative Diseases. The author has an h-index of 5, co-authored 5 publications.
https://doi.org/10.1002/alz.12302
https://doi.org/10.1016/j.jneumeth.2021.109180
Click to start Chat